Migraine is now understood as a neurovascular disorder involving abnormal brain excitability, activation of pain pathways, and inflammation around cranial blood vessels. Older theories focused mainly on vasodilation, but standard texts like Harrison's Principles of Internal Medicine explain that migraine is primarily a disorder of the nervous system with secondary vascular changes. Simplified Pathophysiology of Migraine 1. Triggering Phase — “Hyperexcitable Brain” People with migraine have a genetically sensitive or hyperexcitable brain. Common triggers: Stress Lack of sleep Hormonal changes Certain foods Bright light Fasting These triggers activate specific brain regions, especially: Hypothalamus Brainstem nuclei Cortex This explains early symptoms before headache: Yawning Food cravings Mood change Fatigue 2. Cortical Spreading Depression (Especially in Migraine With Aura) A wave of neuronal depolarization spreads slowly across the cerebral cortex. This is called: Cortical Spreading Depression (CSD) Sequence: Sudden neuronal activation Followed by suppression of brain activity Changes in blood flow occur secondarily Rate: About 2–6 mm/min across cortex Effects: Causes aura symptoms: Flashing lights Zig-zag lines Numbness Speech difficulty CSD also activates trigeminal pain pathways. 3. Activation of the Trigeminovascular System (Most Important Step) This is central to migraine pain. The trigeminal nerve supplies: Meninges Large cerebral vessels When activated, trigeminal nerve endings release neuropeptides: CGRP (Calcitonin Gene-Related Peptide) Substance P Neurokinin A These cause: Vasodilation Plasma protein leakage Sterile neurogenic inflammation Result: Throbbing headache pain CGRP is especially important because: Its level rises during attacks CGRP blockers improve migraine 4. Central Sensitization Repeated pain signaling sensitizes neurons in: Trigeminal nucleus caudalis Thalamus This makes the brain overly responsive. Consequences: Normal touch becomes painful Scalp tenderness Pain worsens with movement Sensitivity to light and sound This explains: Allodynia Photophobia Phonophobia 5. Brainstem Dysfunction Brainstem nuclei involved: Dorsal raphe nucleus (serotonin) Locus coeruleus (noradrenaline) Altered neurotransmitters: Serotonin ↓ during attack Dopamine involvement This contributes to: Nausea Vomiting Autonomic symptoms Important Neurotransmitters in Migraine Neurotransmitter Role CGRP Major mediator of pain and vasodilation Serotonin (5-HT) Modulates trigeminal pathways Dopamine Nausea, yawning, prodrome Glutamate Cortical excitability and CSD Why Triptans Work Triptans are: 5-HT1B/1D agonists They: Inhibit CGRP release Reduce trigeminal transmission Cause cranial vasoconstriction Thus they abort migraine attacks. One-Line Flowchart Trigger ↓ Brain hyperexcitability ↓ Cortical spreading depression (± aura) ↓ Trigeminovascular activation ↓ CGRP release + neurogenic inflammation ↓ Pain transmission to brainstem/thalamus ↓ Migraine headache + sensory symptoms High-Yield Harrison-Based Concepts Migraine is primarily a neuronal disorder, not just vascular. Trigeminovascular activation is the key mechanism of pain. CGRP is central in modern migraine theory. Cortical spreading depression explains aura. Central sensitization causes photophobia and allodynia. Standard References Harrison's Principles of Internal Medicine — Chapter on Headache and Migraine Adams and Victor's Principles of Neurology Robbins and Cotran Pathologic Basis of Disease Davidson's Principles and Practice of
migraine pathophysiology cortical spreading depression trigeminovascular
migraine CGRP pathophysiology trigeminovascular
"It seems probable that there is not a single 'migraine generator' shared by all people with migraine and that there is not a single 'migraine generator' within individuals from attack to attack."
"It is debated whether or not CSD can lead to activation of the trigeminocervical system and thus trigger the headache phase." - Bradley & Daroff
"Activation of these fibers releases substance P, CGRP, and other peptides into the vessel wall, which serves to sensitize the trigeminal system to the pulsatility of cranial vessels, and to increase their permeability, thereby promoting an inflammatory response."
"Recurrent and/or prolonged activation of the trigeminocervical system can lead to peripheral and central sensitization. Sensitized neurons have lower thresholds for activation, increased spontaneous activity, and receptive field expansion. Approximately three-fourths of people with migraine have evidence of cutaneous allodynia during a migraine attack."
"Plasma and platelet concentrations of 5HT vary with different phases of the migraine attack. Urinary concentrations of 5HT and its metabolites are elevated during most migraine attacks. Migraine may be precipitated by agents (e.g., reserpine and fenfluramine) that release 5HT from intracellular storage sites."
| Neurotransmitter/Mediator | Role | Notes |
|---|---|---|
| CGRP | Primary mediator of pain and vasodilation | Target of gepants and anti-CGRP antibodies |
| Serotonin (5-HT) | Modulates trigeminal pathways; fluctuates across attack phases | Levels vary by phase, not simply "decrease" |
| Dopamine | Nausea, yawning, prodrome | Dopamine receptor sensitivity may be increased in migraineurs |
| Glutamate | Cortical excitability and CSD propagation | NMDA receptor involvement in central sensitization |
| Substance P | Released with CGRP; neurogenic inflammation | Less targeted therapeutically than CGRP |
| Nitric oxide (NO) | Vasodilation; triggers migraine; released from trigeminovascular neurons | Missing from your summary - nitroglycerin (a NO donor) is used to experimentally trigger migraine attacks |
| Neurokinin A | Released with CGRP/SP from trigeminal endings | Your summary mentions it - correct |
"One hypothesis... activation of 5HT1B/1D receptors may cause constriction of intracranial blood vessels... An alternative hypothesis proposes that both 5HT1B and 5HT1D receptors serve as presynaptic autoreceptors that block the release of neurotransmitter or proinflammatory neuropeptides at nerve terminals in the perivascular space."
| Missing Concept | Source | Importance |
|---|---|---|
| Periaqueductal gray (PAG) activation | Bradley & Daroff, Adams & Victor | Key imaging finding in premonitory phase; descending pain modulation |
| Nitric oxide (NO) as a mediator | Guyton & Hall | Nitroglycerin triggers migraine experimentally |
| CSD's causal link to headache is debated | Bradley & Daroff | Intellectual honesty; CSD clearly explains aura, pain link less certain |
| 75% of migraineurs develop cutaneous allodynia | Bradley & Daroff | High-yield stat |
| Early triptan use required before central sensitization | Textbook principle | Major clinical implication of the sensitization model |
| Triptan vasoconstriction mechanism (5-HT1B) | Goodman & Gilman | Explains contraindication in CVD |
| PACAP as emerging mediator/target | Recent reviews | Beyond CGRP; emerging therapeutics |
| Oligemia does not respect arterial territories | Adams & Victor, Bradley & Daroff | Directly refutes the vasospasm theory |
| Osmophobia - highly specific for migraine | Bradley & Daroff | Diagnostic specificity |
| Anti-CGRP monoclonal antibodies (gepants, erenumab, etc.) | Current knowledge | Major therapeutic advancement |
| Postdrome phase | Bradley & Daroff | Migraine has 4 phases: prodrome, aura, headache, postdrome |
| Your Claim | Verdict | Notes |
|---|---|---|
| Migraine is neuronal, not purely vascular | ✅ Confirmed | Well-supported across all texts |
| CSD rate "2-6 mm/min" | ⚠️ Slightly high | Textbooks say 2-4 mm/min |
| Hypothalamus + brainstem as trigger regions | ✅ Confirmed | PAG should be added |
| Trigeminal nerve releases CGRP, SP, Neurokinin A | ✅ Confirmed | Add NO |
| Sterile neurogenic inflammation | ✅ Confirmed | Classic Moskowitz model |
| Central sensitization - trigeminal nucleus caudalis + thalamus | ✅ Confirmed | Add: 75% allodynia rate |
| Serotonin ↓ during attack | ⚠️ Oversimplified | 5-HT levels vary by phase |
| Triptans = 5-HT1B/1D agonists | ✅ Confirmed | Add vasoconstriction mechanism and CVD contraindication |
| CSD activates trigeminal pain pathways | ⚠️ Debated | Textbooks explicitly call this debated |
Generate a PDF quick-reference card on migraine pathophysiology
Migraine Pathophysiology QuickRef
PDF Document · PDF
Make it in simplified way for me to understand as I am UG student
Migraine SimpleGuide UG
PDF Document · PDF
Explain the pathophysiology of migraine in a simplified way with reference of standard textbooks like harrison
"Migraine is primarily a disorder of the nervous system — the brain dysfunction comes first. Blood vessel changes are secondary, not the cause." — Harrison's Principles of Internal Medicine 22e
"Migraineurs are particularly sensitive to environmental and sensory stimuli; migraine-prone patients do not habituate easily to sensory stimuli."
| Trigger | Simple Explanation |
|---|---|
| Stress (or stress let-down) | Brain suddenly relaxes after being tense |
| Sleep changes | Disrupts brainstem control of pain pathways |
| Skipping meals / fasting | Low glucose affects brain metabolism |
| Hormonal changes | Estrogen drop before menstruation is a major trigger |
| Bright lights / loud sounds | Brain is already too sensitive |
| Certain foods / alcohol | Chemical stimulation (especially nitrates in wine) |
| Barometric pressure changes | Sensory overload in a sensitive brain |
"The sensory sensitivity that is characteristic of migraine is probably due to dysfunction of monoaminergic and other sensory control systems located in the brainstem and hypothalamus."
Important: CSD clearly explains the AURA. Whether CSD directly triggers the headache phase is still debated in the literature (Bradley & Daroff, 2023).
"The innervation of the large intracranial vessels and dura mater by the trigeminal nerve is known as the trigeminovascular system."
| Chemical | What it does |
|---|---|
| CGRP (Calcitonin Gene-Related Peptide) | Dilates blood vessels; major pain signaller - the MOST important |
| PACAP (Pituitary Adenylate Cyclase-Activating Polypeptide) | Similar to CGRP; newer target of therapy (Harrison's 22e) |
| Substance P | Causes plasma protein leakage from vessels |
| Nitric Oxide (NO) | Vasodilator; nitroglycerin (a NO donor) reliably triggers migraine |
"CGRP receptor antagonists, gepants, have now been shown to be effective in the acute and preventive treatment of migraine, and four monoclonal antibodies to CGRP, or its receptor, have been shown to be effective in migraine prevention."
"Recurrent and/or prolonged activation of the trigeminocervical system can lead to peripheral and central sensitization. Sensitized neurons have lower thresholds for activation, increased spontaneous activity, and receptive field expansion."
1st order neuron sensitized → trigeminal nerve endings
↓
2nd order neuron sensitized → trigeminal nucleus caudalis
↓ (allodynia begins here - scalp tenderness)
3rd order neuron sensitized → thalamus + cortex
↓ (whole-body allodynia, photophobia, phonophobia)
Clinical importance: Once allodynia (central sensitization) is established, triptans become LESS effective. This is why early treatment is emphasised.
| System | Normal role | In Migraine |
|---|---|---|
| Serotonin (5-HT) via Dorsal Raphe Nucleus | Descending pain suppression | Fluctuates across attack phases; levels drop during acute attack |
| Noradrenaline via Locus Coeruleus | Arousal, attention, pain modulation | Dysregulated; contributes to sensory hypersensitivity |
| Dopamine | Controls prodrome symptoms | D2 receptor hypersensitivity; causes yawning, nausea |
"In the late 1950s, methysergide was suggested to antagonize certain peripheral actions of 5-HT and was introduced as a migraine preventive... The triptans were designed to stimulate selectively subpopulations of 5-HT receptors."
"Triptans arrest nerve signaling in the nociceptive pathways of the trigeminovascular system, at least in the trigeminal nucleus caudalis and trigeminal sensory thalamus, in addition to promoting cranial vasoconstriction."
TRIGGERS (stress, sleep, hormones, food, light)
↓
HYPOTHALAMUS + BRAINSTEM over-activate
(prodrome: yawning, cravings, fatigue — hours before pain)
↓
CORTICAL SPREADING DEPRESSION [in 25-30%]
(wave of depolarization, 2-4 mm/min, occipital → frontal)
↓ → AURA (zig-zag lights, numbness, dysphasia)
TRIGEMINOVASCULAR ACTIVATION
(trigeminal nerve fires → CGRP + Substance P + NO released)
↓
STERILE NEUROGENIC INFLAMMATION
(meningeal vessels dilate, plasma leaks, inflammation forms)
↓
PAIN SIGNALS → trigeminal nucleus caudalis → thalamus → cortex
= THROBBING HEADACHE (usually unilateral, 4-72 hours)
↓
CENTRAL SENSITIZATION
(allodynia, photophobia, phonophobia, osmophobia)
↓
POSTDROME (fatigue, brain fog, neck stiffness — the "hangover")
| Concept | Key Point | Source |
|---|---|---|
| Migraine is neuronal, NOT vascular | Blood vessel changes are secondary | Harrison's 22e |
| Key structure | Trigeminovascular system | Harrison's, Adams & Victor |
| Main pain chemical | CGRP (and PACAP) | Harrison's 22e |
| Basis of aura | Cortical Spreading Depression (CSD) | Bradley & Daroff |
| CSD rate | 2-4 mm/min (occipital to frontal) | Bradley & Daroff |
| CSD and headache link | Still debated | Bradley & Daroff |
| Allodynia prevalence | ~75% during attacks | Bradley & Daroff |
| Triptan mechanism | 5-HT1B (vasoconstriction) + 5-HT1D (blocks CGRP release) | Harrison's 22e, Goodman & Gilman |
| Newer drugs | Gepants (CGRP antagonists), anti-CGRP mAbs, ditans | Harrison's 22e |
| Migraine prevalence | 15% women, 6% men; most disabling neurological condition worldwide | Harrison's 22e |
Make a visual flowchart poster showing the complete migraine pathway
Migraine Flowchart Poster
PDF Document · PDF
| Step | Node | Colour |
|---|---|---|
| 1 | Triggers | Grey |
| 2 | Hyperexcitable Brain | Blue |
| 3 | Cortical Spreading Depression | Orange |
| 4 | Trigeminovascular Activation | Red |
| 5 | Sterile Neurogenic Inflammation | Purple |
| 6 | Central Sensitization | Purple |
| 7 | MIGRAINE HEADACHE (highlighted focal box) | Red |
| 8 | Postdrome | Grey |